Expression of angiotensin II and its receptors in the normal and hypoxic amoeboid microglial cells and murine BV-2 cells

Neuroscience

Volumn 158, Issue 4, 2009, Pages 1488-1499

  Li, J J ^a   Lu, J ^c   Kaur, C ^b   Sivakumar, V ^b   Wu, C Y ^a   Ling, E A ^b  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c DSO NATIONAL LABORATORIES   (Singapore)

Author keywords

angiotensin II; AT1; AT2; BV 2 cells; hypoxia; microglial cells

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR TYPE 1; ANGIOTENSIN 2 RECEPTOR TYPE 2; ANGIOTENSIN II; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; NORPHENAZONE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CORPUS CALLOSUM; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME IMMUNOASSAY; HYPOXIA; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; RECEPTOR UPREGULATION; SERODIAGNOSIS; VASODILATATION; WISTAR RAT;

ANGIOTENSIN II; ANIMALS; ANIMALS, NEWBORN; ANOXIA; ANTIBODIES; ANTIPYRINE; CELL HYPOXIA; CELLS, CULTURED; CORPUS CALLOSUM; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FREE RADICAL SCAVENGERS; GENE EXPRESSION REGULATION; IMMUNOENZYME TECHNIQUES; LIPOPOLYSACCHARIDES; MICE; MICROGLIA; RATS; RATS, WISTAR; RECEPTORS, ANGIOTENSIN; RNA, MESSENGER; TIME FACTORS;

EID: 60149111427     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.11.046     Document Type: Article

References (56)

1. Abe K., Yuki S., and Kogure K. Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger. Stroke 19 (1988) 480-485
2. Aizawa H., Makita Y., Sumitomo K., Aburakawa Y., Katayama T., Nakatani-Enomoto S., Suzuki Y., Fujiwara K., Enomoto H., Kuroda K., Kimura T., Yahara O., Koyama S., Maruyama J., Nakamura M., Hasebe N., and Kikuchi K. Edaravone diminishes free radicals from circulating neutrophils in patients with ischemic brain attack. Intern Med 45 (2006) 1-4
3. 1 receptor blockade reverses pathological hypertrophy and inflammation in brain microvessels of spontaneously hypertensive rats. Stroke 35 (2004) 1726-1731
4. 1 receptor antagonism parallels improved vascular morphology in hypertensive rats. J Am Soc Nephrol 10 (1999) S104-S115
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
6. 2 receptors. Kidney Int Suppl 67 (1998) S95-S99
7. Culman J., Baulmann J., Blume A., and Unger T. The renin-angiotensin system in the brain: an update. J Renin Angiotensin Aldosterone Syst 2 (2001) 96-102
8. Dai W.J., Funk A., Herdegen T., Unger T., and Culman J. Blockade of central angiotensin AT(1) receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats. Stroke 30 (1999) 2391-2398
9. Danielyan L., Lourhmati A., Verleysdonk S., Kabisch D., Proksch B., Thiess U., Umbreen S., Schmidt B., and Gleiter C.H. Angiotensin receptor type1 blockade in astroglia decreases hypoxia-induced cell damage and TNF alpha release. Neurochem Res 32 (2007) 1489-1498
10. de Gasparo M., Catt K.J., Inagami T., Wright J.W., and Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52 (2000) 415-472
11. Dheen S.T., Jun Y., Yan Z., Tay S.S., and Ling E.A. Retinoic acid inhibits expression of TNF-alpha and iNOS in activated rat microglia. Glia 50 (2005) 21-31
12. Egidy G., Friedman J., Viswanathan M., Wahl L.M., and Saavedra J.M. CGP-42112 partially activates human monocytes and reduces their stimulation by lipopolysaccharides. Am J Physiol 273 (1997) C826-C833
13. Fogarty D.J., and Matute C. Angiotensin receptor-like immunoreactivity in adult brain white matter astrocytes and oligodendrocytes. Glia 35 (2001) 131-146
14. Gomez R.A., Cassis L., Lynch K.R., Chevalier R.L., Wilfong N., Carey R.M., and Peach M.J. Fetal expression of the angiotensinogen gene. Endocrinology 123 (1988) 2298-2302
15. Grammatopoulos T., Morris K., Ferguson P., and Weyhenmeyer J. Angiotensin protects cortical neurons from hypoxic-induced apoptosis via the angiotensin type 2 receptor. Mol Brain Res 99 (2002) 114-124
16. Hermann K., Raizada M.K., Sumners C., and Phillips M.I. Presence of renin in primary neuronal and glial cells from rat brain. Brain Res 437 (1987) 205-213
17. Hermann K., Raizada M.K., Sumners C., and Phillips M.I. Immunocytochemical and biochemical characterization of angiotensin I and II in cultured neuronal and glial cells from rat brain. Neuroendocrinology 47 (1988) 125-132
18. 1 antagonist. Stroke 33 (2002) 2297-2303
19. 1 receptor reduces apoptosis, inflammation, and oxidative stress in normotensive rats with intracerebral hemorrhage. J Pharmacol Exp Ther 322 (2007) 1051-1058
20. Kaur C., Ling E.A., and Wong W.C. Transformation of amoeboid microglial cells into microglia in the corpus callosum of the postnatal rat brain. An electron microscopical study. Arch Histol Jpn 48 (1985) 17-25
21. Kaur C., and Ling E.A. Study of the transformation of amoeboid microglial cells into microglia labelled with the isolectin Griffonia simplicifolia in postnatal rat. Acta Anat 142 (1991) 118-125
22. Kaur C., Sivakumar V., Ang L.S., and Sundaresan A. Hypoxic damage to the periventricular white matter in neonatal brain: role of vascular endothelial growth factor, nitric oxide and excitotoxicity. J Neurochem 98 (2006) 1200-1216
23. Lacroix S., Feinstein D., and Rivest S. The bacterial endotoxin lipopolysaccharide has the ability to target the brain in upregulating its membrane CD14 receptor within specific cellular populations. Brain Pathol 8 (1998) 625-640
24. 1 receptors. J Biol Chem 271 (1996) 22729-22735
25. 2 receptor protects against cerebral ischemia-induced neuronal injury. FASEB J 19 (2005) 617-619
26. Lind R.W., Swanson L.W., and Ganten D. Organization of angiotensin II immunoreactive cells and fibres in the rat central nervous system: an immunocytochemical study. Neuroendocrinology 40 (1985) 2-24
27. Ling E.A., and Wong W.C. The origin and nature of ramified and amoeboid microglia: a historical review and current concepts. Glia 7 (1993) 9-18
28. Ling E.A., Ng Y.K., Wu C.H., and Kaur C. Microglia: its development and role as a neuropathology sensor. Prog Brain Res 132 (2001) 61-79
29. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-delta delta C (T) method. Methods 24 (2001) 402-408
30. 2 receptor mRNA level after global ischemia in the rat brain. Neuropeptides 30 (1996) 596-601
31. 2 receptor inhibits proliferation and promotes differentiation in PC12W cells. Mol Cell Endocrinol 122 (1996) 59-67
32. Millan M.A., Kiss A., and Aguilera G. Developmental changes in brain angiotensin II receptors in the rat. Peptides 12 (1991) 723-737
33. Milstead A., Barna B.P., Ransohoff R.M., Brosnihan K.B., and Ferrario C.M. Astrocyte cultures derived from human brain tissue express angiotensinogen mRNA. Proc Natl Acad Sci U S A 87 (1990) 5720-5723
34. Miyoshi M., Miyano K., Moriygma N., Taniguchi M., and Watanabe T. Angiotensin type 1 receptor antagonist inhibits lipopolysaccharide-induced stimulation of rat microglial cells by suppressing nuclear factor κB and activator protein activation. Eur J Neurosci 27 (2008) 343-351
35. Mungall B.A., Shinkel T.A., and Sernia C. Immunocytochemical localization of angiotensinogen in the fetal and neonatal rat brain. Neuroscience 67 (1995) 505-524
36. 1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci U S A 92 (1995) 10663-10667
37. Nio Y., Matsubara H., Murasawa S., Kanasaki M., and Inada M. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest 95 (1995) 46-54
38. Okamura A., Rakugi H., Ohishi M., Yanagitani Y., Takiuchi S., Moriguchi K., Fennessy P.A., Higaki J., and Ogihara T. Upregulation of rennin±angiotensin system during differentiation of monocytes to macrophages. J Hypertens 17 (1999) 537-545
39. Petrossian G., and Oliver J.A. Synthesis of angiotensinogen by renin-containing neuroblastomas. Am J Physiol 257 (1989) C185-C189
40. Phillips M.I., Speakman E.A., and Kimura B. Levels of angiotensin and molecular biology of the tissue renin angiotensin systems. Regul Pept 43 (1993) l-20
41. Richoux J.P., Bouhnik J., Clauser E., and Corvol P. The renin-angiotensin system in the rat brain: Immunocytochemical localisation of angiotensinogen in glial cells and neurons. Histochemistry 89 (1988) 323-331
42. Sood P.P., Panigel M., and Wegmann R.J. The existence of a renin-angiotensinogen system in the rat fetal brain: I. immunocytochemical localisation of renin-like activity at the 19th day of gestation. Cell Mol Biol 33 (1987) 675-680
43. Sood P.P., Richoux J.P., Panigel M., Bouhnik J., and Wegmann R. The existence of renin-angiotensinogen system in the fetal rat brain: II. Immunocytochemical localization of angiotensinogen in the telencephalon and the diencephalon. Cell Mol Biol 33 (1987) 681-689
44. 2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 95 (1995) 651-657
45. 2 receptor: new insights into an old system. Regul Pept 99 (2001) 175-182
46. Thomas W.G., Greenland K.J., Shinkel T.A., and Sernia C. Angiotensinogen is secreted by pure rat neuronal cell cultures. Brain Res 588 (1992) 191-200
47. Tsutsumi K., Viswanathan M., Stromberg C., and Saavedra J.M. Type-l and type-2 angiotensin II receptors in fetal rat brain. Eur J Pharm 198 (1991) 89-92
48. Uno M., Kitazato K.T., Suzue A., Matsuzaki K., Harada M., Itabe H., and Nagahiro S. Inhibition of brain damage by edaravone, a free radical scavenger, can be monitored by plasma biomarkers that detect oxidative and astrocyte damage in patients with acute cerebral infarction. Free Radic Biol Med 39 (2005) 1109-1116
49. Vannucci R.C., Lyons D.T., and Vasta F. Regional cerebral blood flow during hypoxia-ischemia in immature rats. Stroke 19 (1988) 245-250
50. 2 receptors in the rat skin during experimental wound healing. Peptides 13 (1992) 783-786
51. Weyhenmeyer J.A., Meyer J.M., and Watkins J.E. Angiotensin II synthesis studies in dissociated brain cell cultures. J Neurochem 43 (1984) 716-723
52. William R.S., Robert A., Paul F., Brent O., Evan K., and James A.W. Angiotensin II attenuates NMDA receptor-mediated neuronal cell death and prevents the associated reduction in Bcl-2 expression. Mol Brain Res 128 (2004) 20-29
53. Wu C.H., Wen C.Y., Shieh J.Y., and Ling E.A. Downregulation of membrane glycoprotein in amoeboid microglia transforming into ramified microglia in the postnatal rat brain. J Neurocytol 23 (1994) 258-269
54. Wu C.Y., Kaur C., Lu J., Cao Q., Guo C.H., Zhou Y., Sivakumar V., and Ling E.A. Transient expression of endothelins in the amoeboid microglial cells in the developing rat brain. Glia 54 (2006) 513-525
55. Yamamoto T., Yuki S., Watanabe T., Mitsuka M., Saito K.I., and Kogure K. Delayed neuronal death prevented by inhibition of increased hydroxyl radical formation in a transient cerebral ischemia. Brain Res 762 (1997) 240-242
56. Zhang N., Komine-Kobayashi M., Tanaka R., Liu M., Mizuno Y., and Urabe T. Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain. Stroke 36 (2005) 2220-2225